NUBACT XL

NUBACT XL

An unique combination of well studied strains of streptococcus fecalis, Clostridium Butyricum, Bacillus Mesentericus and Bacillus Coagulans is effective in the management of Non-alcoholic fatty liver disease (NAFLD), Non-alcoholic Steato Hepatosis (NASH), Inflammatory Bowel Disease – Crohn’s Disease / Ulcerative Colitis, Clostridium difficle associated Diarrhea – co-prescribed with Proton Pump Inhibitors (PPIs).

NUBACT XL

An unique combination of well studied strains of streptococcus fecalis, Clostridium Butyricum, Bacillus Mesentericus and Bacillus Coagulans is effective in the management of Non-alcoholic fatty liver disease (NAFLD), Non-alcoholic Steato Hepatosis (NASH), Inflammatory Bowel Disease – Crohn’s Disease / Ulcerative Colitis, Clostridium difficle associated Diarrhea – co-prescribed with Proton Pump Inhibitors (PPIs).

.

Therapeutic Uses:

Ingredients:

Each 0.5 g sachet contains:

Visited 162 times, 1 visit(s) today
Close Search Window
Close